Authors: WOO IS PARK YS PARK YI LEE JA AHN JS BAE HS KIM WS PARK KC KIM HJ AHN YC

Citation: Is. Woo et al., A PHASE-II STUDY OF VP-16-IFOSFAMIDE-CISPLATIN (VIP) PLUS EARLY CONCURRENT THORACIC IRRADIATION (TI) FOR PREVIOUSLY UNTREATED LIMITED SMALL-CELL LUNG-CANCER (SCLC), Annals of oncology, 9, 1998, pp. 500-500